|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2004-7-22
|
|
pubmed:abstractText |
The purpose of this study was to investigate the antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG; NSC707545), a water-soluble benzoquinone ansamycin.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/17-(allylamino)-17-demethoxygeldanam...,
http://linkedlifedata.com/resource/pubmed/chemical/17-(dimethylaminoethylamino)-17-deme...,
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD31,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoquinones,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factor 2,
http://linkedlifedata.com/resource/pubmed/chemical/HSP90 Heat-Shock Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Lactams, Macrocyclic,
http://linkedlifedata.com/resource/pubmed/chemical/Laminin,
http://linkedlifedata.com/resource/pubmed/chemical/Proteoglycans,
http://linkedlifedata.com/resource/pubmed/chemical/Quinones,
http://linkedlifedata.com/resource/pubmed/chemical/Rifabutin,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A,
http://linkedlifedata.com/resource/pubmed/chemical/matrigel
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4813-21
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:15269157-Administration, Oral,
pubmed-meshheading:15269157-Angiogenesis Inhibitors,
pubmed-meshheading:15269157-Animals,
pubmed-meshheading:15269157-Antigens, CD31,
pubmed-meshheading:15269157-Apoptosis,
pubmed-meshheading:15269157-Benzoquinones,
pubmed-meshheading:15269157-Biological Availability,
pubmed-meshheading:15269157-Blood Vessels,
pubmed-meshheading:15269157-Cell Line,
pubmed-meshheading:15269157-Cell Movement,
pubmed-meshheading:15269157-Cell Proliferation,
pubmed-meshheading:15269157-Collagen,
pubmed-meshheading:15269157-Drug Combinations,
pubmed-meshheading:15269157-Endothelial Cells,
pubmed-meshheading:15269157-Female,
pubmed-meshheading:15269157-Fibroblast Growth Factor 2,
pubmed-meshheading:15269157-HSP90 Heat-Shock Proteins,
pubmed-meshheading:15269157-Humans,
pubmed-meshheading:15269157-Immunoblotting,
pubmed-meshheading:15269157-Immunohistochemistry,
pubmed-meshheading:15269157-Lactams, Macrocyclic,
pubmed-meshheading:15269157-Laminin,
pubmed-meshheading:15269157-Mice,
pubmed-meshheading:15269157-Mice, Inbred C57BL,
pubmed-meshheading:15269157-Proteoglycans,
pubmed-meshheading:15269157-Quinones,
pubmed-meshheading:15269157-Rifabutin,
pubmed-meshheading:15269157-Time Factors,
pubmed-meshheading:15269157-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.
|
|
pubmed:affiliation |
Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|
